Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
BLUEJETNSE
Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 14% | 10% | -8% |
| - | 12% | 16% | -19% |
| - | - | - | -15% |
| 30% | 28% | 24% | 20% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
BLUEJET
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 573.75 | ₹11076 Cr | 47.15 | 4.51 | 13.73 | ₹248 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹10 Cr |
| ₹1325 Cr | ₹1098 Cr | ₹811 Cr | ₹647 Cr | ₹487 Cr | ₹330 Cr |
| ₹1325 Cr | ₹1098 Cr | ₹811 Cr | ₹647 Cr | ₹487 Cr | ₹330 Cr |
| ₹1360 Cr | ₹1133 Cr | ₹845 Cr | ₹681 Cr | ₹522 Cr | ₹340 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹29 Cr |
| ₹11 Cr | ₹7 Cr | ₹3 Cr | ₹1 Cr | ₹26 L | ₹1 Cr |
| ₹38 Cr | ₹17 Cr | ₹38 L | ₹2 Cr | ₹13 Cr | ₹1 L |
| ₹302 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr |
| ₹350 Cr | ₹29 Cr | ₹8 Cr | ₹7 Cr | ₹17 Cr | ₹33 Cr |
| — | — | — | — | — | — |
| ₹57 Cr | ₹89 Cr | ₹30 Cr | ₹54 Cr | ₹57 Cr | ₹60 Cr |
| ₹56 Cr | ₹34 Cr | ₹51 Cr | ₹39 Cr | ₹32 Cr | ₹46 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹7 Cr |
| ₹164 Cr | ₹378 Cr | ₹281 Cr | ₹226 Cr | ₹170 Cr | ₹107 Cr |
| ₹277 Cr | ₹501 Cr | ₹362 Cr | ₹318 Cr | ₹259 Cr | ₹220 Cr |
| ₹1987 Cr | ₹1662 Cr | ₹1214 Cr | ₹1007 Cr | ₹798 Cr | ₹593 Cr |
| ₹68 L | ₹68 L | ₹1 Cr | ₹12 Cr | ₹2 Cr | ₹2 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹52 Cr |
| — | — | — | — | — | — |
| ₹458 Cr | ₹421 Cr | ₹276 Cr | ₹231 Cr | ₹215 Cr | ₹176 Cr |
| ₹141 Cr | ₹121 Cr | ₹104 Cr | ₹80 Cr | ₹58 Cr | ₹37 Cr |
| ₹316 Cr | ₹300 Cr | ₹172 Cr | ₹151 Cr | ₹156 Cr | ₹139 Cr |
| ₹301 Cr | ₹89 Cr | ₹147 Cr | ₹30 Cr | ₹3 Cr | ₹3 Cr |
| ₹25 Cr | ₹0 | ₹15 Cr | ₹0 | ₹0 | ₹0 |
| ₹25 Cr | ₹0 | ₹15 Cr | ₹0 | ₹0 | ₹0 |
| ₹324 Cr | ₹22 Cr | ₹19 Cr | ₹15 Cr | ₹5 Cr | ₹5 Cr |
| ₹14 Cr | ₹39 L | ₹24 L | ₹17 L | ₹10 L | ₹8 L |
| ₹981 Cr | ₹412 Cr | ₹353 Cr | ₹197 Cr | ₹165 Cr | ₹146 Cr |
| — | — | — | — | — | — |
| ₹227 Cr | ₹187 Cr | ₹235 Cr | ₹189 Cr | ₹94 Cr | ₹37 Cr |
| ₹187 Cr | ₹264 Cr | ₹130 Cr | ₹126 Cr | ₹105 Cr | ₹118 Cr |
| ₹339 Cr | ₹350 Cr | ₹177 Cr | ₹239 Cr | ₹227 Cr | ₹144 Cr |
| ₹149 Cr | ₹120 Cr | ₹85 Cr | ₹66 Cr | ₹88 Cr | ₹70 Cr |
| ₹18 Cr | ₹7 Cr | ₹15 Cr | ₹18 Cr | ₹8 Cr | ₹4 Cr |
| ₹86 Cr | ₹324 Cr | ₹219 Cr | ₹172 Cr | ₹111 Cr | ₹74 Cr |
| ₹1006 Cr | ₹1251 Cr | ₹861 Cr | ₹810 Cr | ₹633 Cr | ₹447 Cr |
| ₹730 Cr | ₹750 Cr | ₹500 Cr | ₹491 Cr | ₹374 Cr | ₹227 Cr |
| ₹1987 Cr | ₹1662 Cr | ₹1214 Cr | ₹1007 Cr | ₹798 Cr | ₹593 Cr |
| ₹78 | ₹65 | ₹49 | ₹39 | ₹30 | ₹3,428 |
| ₹78 | ₹65 | ₹49 | ₹39 | ₹30 | ₹20 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ₹333 Cr | ₹406 Cr | ₹220 Cr | ₹217 Cr | ₹243 Cr | ₹190 Cr |
| ₹1 Cr | -₹8 Cr | ₹19 Cr | ₹18 Cr | ₹7 Cr | ₹17 Cr |
| ₹109 Cr | -₹263 Cr | ₹13 Cr | -₹33 Cr | -₹76 Cr | -₹73 Cr |
| ₹443 Cr | ₹135 Cr | ₹252 Cr | ₹202 Cr | ₹174 Cr | ₹135 Cr |
| ₹334 Cr | ₹46 Cr | ₹241 Cr | ₹142 Cr | ₹146 Cr | ₹135 Cr |
| -₹276 Cr | -₹35 Cr | -₹264 Cr | -₹147 Cr | -₹76 Cr | -₹56 Cr |
| -₹31 Cr | -₹19 Cr | -₹2 Cr | -₹4 Cr | -₹56 Cr | -₹27 Cr |
| ₹28 Cr | -₹8 Cr | -₹24 Cr | -₹10 Cr | ₹14 Cr | ₹51 Cr |
| ₹33 Cr | ₹41 Cr | ₹65 Cr | ₹75 Cr | ₹61 Cr | ₹10 Cr |
| ₹61 Cr | ₹33 Cr | ₹41 Cr | ₹65 Cr | ₹75 Cr | ₹61 Cr |
Fundamental Ratios
Consolidated
Standalone
Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 5 out of 9 oscillators
RSI
47.62Neutral
STOCH %K
50.42Neutral
MACD Level(12,26)
-1.42Sell
Ultimate Oscillator
41.96Sell
Aroon Oscillator
-62.00Sell
BOP
-0.42Sell
CCI
25.33Neutral
Williams %R
-49.58Neutral
Momentum
-5.55Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 moving averages
EMA 9
576.65Sell
SMA 9
572.65Buy
EMA 21
577.54Sell
SMA 21
576.31Sell
EMA 50
571.67Buy
SMA 50
584.57Sell
EMA 200
552.19Buy
SMA 200
489.93Buy
WMA 20
574.75Sell
Pivot
Pivot
Classic
Resistance 5
652.07
Resistance 4
635.62
Resistance 3
619.17
Resistance 2
602.72
Resistance 1
594.23
Pivot
586.27
Support 1
577.78
Support 2
569.82
Support 3
553.37
Support 4
536.92
Support 5
520.47
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 79.81% | 79.81% | 79.81% | 79.81% | 86.00% | 86.00% |
| 0.40% | 0.89% | 1.14% | 1.83% | 1.97% | 2.28% |
| 2.93% | 2.89% | 2.64% | 1.86% | 0.45% | 0.71% |
| 1.72% | 1.62% | 2.01% | 1.77% | 0.50% | 0.62% |
| 15.14% | 14.79% | 14.40% | 14.73% | 11.08% | 10.39% |
Bulk & block deals
Name
Norges Bank On Account Of The Government Pension Fund Global
Valuequest Investment Advisors Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 01 Nov 2023 | Purchase | 79.80 Cr | ₹380 | 21 L | Bulk | 1.210616 | NSE |
| 01 Nov 2023 | Purchase | 44.14 Cr | ₹388 | 11.38 L | Bulk | 0.655774 | NSE |
Insider trading & SAST
Client name
Akshay Bansarilal Arora
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep 2025 | Promoter | Disposal | 6.19 | 62.8 | 0 | — | 1.07 Cr | 10 Sep 2025 - 11 Sep 2025 | Offer For Sale | 10,89,35,795 | SAST | 29(2) | — |
Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
Blue Jet Healthcare (Formerly known as Bluejet Healthcare Private Limited) is a Public Limited Company (converted from private limited to public limited company on May 18, 2022) incorporated in India
Corporate Actions
Date
Type
Details
Company details
Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Blue Jet Healthcare Share Price
573.45-12.30 (-2.10%)
-15.78% past 1 Year
News
Blue Jet Healthcare highlights four chronic therapy programs, two high-conviction
Equity
BLUEJET
Blue Jet Healthcare outlines FY27 product launches and R&D ramp-up roadmap
Equity
BLUEJET
Blue Jet Healthcare updates timeline for Unit 3 backward integration project
Equity
BLUEJET
Blue Jet Healthcare sees sustained PI and API segment strength into FY27
Equity
BLUEJET
Blue Jet Healthcare outlines Rs 1,000 crores multi-year capex roadmap till FY27
Equity
BLUEJET
Blue Jet Healthcare Q1 FY result shows YoY EBITDA decline and margin compression
Equity
BLUEJET
Blue Jet Healthcare reports lower Q1 revenue year on year
Equity
BLUEJET
Blue Jet Healthcare Q1 net profit declines year on year
Equity
BLUEJET
Blue Jet Healthcare schedules Q1 FY2026 earnings call for August 3, evening
Equity
BLUEJET
Blue Jet Healthcare opens QIP at Rs 531.70 with potential 5 percent discount window
Equity
BLUEJET
Blue Jet Healthcare informs about press release
Equity
BLUEJET
Blue Jet Healthcare informs about press release
Equity
BLUEJET
Blue Jet Healthcare - Quaterly Results
Equity
BLUEJET
Blue Jet Healthcare reports Profit after tax of 64.34 Crores, in the March 2026 quarter
Equity
BLUEJET
Blue Jet Healthcare approves fundraising plan worth up to Rs 1,000 crore
Equity
BLUEJET
Blue Jet Healthcare Q4 EBITDA declines year on year amid margin compression
Equity
BLUEJET
Blue Jet Healthcare reports lower quarterly revenue versus year ago
Equity
BLUEJET
Blue Jet Healthcare reports Q4 standalone net profit against prior year
Equity
BLUEJET
Blue Jet Healthcare board to review Q4 results and fundraising on May 25
Equity
BLUEJET
JPMorgan Downgrades Blue Jet Healthcare to Underweight, Cuts Target Price to Rs 330.
Equity
BLUEJET